Pegalin 25 Capsule: Each capsule contains 25 mg Pregabalin INN. Pegalin 50 Capsule: Each capsule contains 50 mg Pregabalin INN. Pegalin 75 Capsule: Each capsule contains 75 mg Pregabalin INN. Pegalin 100 Capsule: Each capsule contains 100 mg Pregabalin INN. Pegalin 150 Capsule: Each capsule contains 150 mg Pregabalin INN.
Dosage and administration:
Pregabalin is given by mouth in 2 or 3 divided doses daily. Fibromyalgia: The initial dose is 75 mg two times a day (150 mg/day) and may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day). Postherpetic Neuralgia: Dosing should begin at 75 mg two times a day (150 mg/day) and may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be further increased to 300 mg two times a day (600 mg/day). Epilepsy: The initial adult dose is 150 mg daily increased after 1 week according to response to 300 mg daily and then to 600 mg daily after another week. Generalised Anxiety Disorder: The initial adult dose is 150 mg daily; this may be increased at weekly intervals in steps of 150 mg, to a maximum of 600 mg daily. Neuropathic Pain: The initial adult dose is 150 mg daily increased after 3 to 7 days according to response to 300 mg daily and then to 600 mg daily after another 7 days. Use in Children and Adolescents (<18 years of age): The safety and effectiveness of pregabalin has not been established in patients below the age of 18 years, with either epilepsy or neuropathic pain. Administration in Renal Impairment
Side effect:
The most common adverse effects reported during therapy with pregabalin are dizziness and somnolence. Other common adverse effects include blurred vision, diplopia, increased appetite and weight gain, dry mouth, constipation, vomiting, flatulence, euphoria, confusion, reduced libido, erectile dysfunction, irritability, vertigo, ataxia, tremor, dysarthria, paraesthesia, fatigue, and oedema. Disturbances of attention, memory, coordination, and gait also occur frequently.
Reviews
There are no reviews yet.